Background/Aims: estrogens and phytoestrogens exert hepatoprotection through mechanisms not clearly examined yet. Here, we investigated the protective effects exerted by 17β-estradiol and genistein against oxidative stress in hepatocytes and hepatic stellate cells (HSCs) and the involvement of specific receptors and the intracellular signalling. Methods: Huh7.5 and LX-2, alone or in co-culture with Huh7.5, were treated with 17β-estradiol and genistein alone or in the presence of menadione and of estrogen receptors (ERs) and G protein-coupled-estrogenic-receptors (GPER) blockers. Cell viability, mitochondrial membrane potential and oxidant/antioxidant system were measured by specific kits. Western Blot was used for the analysis of Akt and p38-mitogen-activated-protein kinases (MAPK) activation and α-smooth-muscle actin expression. Results: In Huh7.5, 17β-estradiol and genistein prevented the effects of peroxidation by modulating Akt and p38MAPK activation. Similar antioxidant and protective findings were obtained in LX-2 of co-culture experiments, only. ERs and GPER blockers were able to prevent the effects of 17β-estradiol and genistein. Conclusion: In Huh7.5 and LX-2, 17β-estradiol and genistein counteract the effects of peroxidation through the involvement of ERs and GPER and by an intracellular signalling related to Akt and p38MAPK. As concerning LX-2, paracrine factors released by Huh7.5 play a key role in protection against oxidative stress.
Modulation of Oxidative Stress by 17 β-Estradiol and Genistein in Human Hepatic Cell Lines In Vitro

Introduction
Oxidative stress is a common pathogenic factor in most liver diseases, including chronic hepatitis C virus (HCV) infection, as well as alcoholic and non-alcoholic fatty liver disease [1] [2] [3] . Parenchymal cells, mainly represented by hepatocytes, are primarily subjected to MTT dye was added in 96-well plates containing the cells and incubated for 2 h at 37°C in an incubator. Thereafter, the medium was removed, and an MTT solubilization solution was added and mixed in a gyratory shaker until the complete dissolution of formazan crystals. Cell viability was determined by measuring the absorbance through a spectrometer (BS1000 Spectra Count, San Jose, CA, USA).
Mitochondrial membrane potential measurement
Mitochondrial membrane potential measurement in Huh7.5 and LX-2 was performed with 5,51,6,61-tetrachloro-1,11,3,31 tetraethylbenzimidazolyl carbocyanine iodide assay. Cells were stimulated as described for cell viability. After stimulations, the medium of cells was removed and incubated with 5,51,6,61-tetrachloro-1,11,3,31 tetraethylbenzimidazolyl carbocyanine iodide 1X diluted in Assay Buffer 1X for 15 min at 37°C in an incubator following the manufacturer's instruction and as previously performed (Invitrogen, Life Technologies Europe BV, Monza, Italy) [13] [14] [15] . The red (excitation 550 nm/emission 600 nm) and green (excitation 485 nm/emission 535 nm) fluorescence was measured using a fluorescence plate reader (BS1000 Spectra Count). To establish the cells undergoing apoptosis, the ratio of red to green fluorescence was determined and expressed as percentage.
Glutathione (GSH) quantification
In Huh7.5 and LX-2 treated with genistein (10 pM; 100 nM; 1 μM) and 17 β estradiol (10 pM; 10 nM; 100 nM), as described for cell viability and mitochondrial membrane potential measurement, the content of GSH was determined by using a commercial kit according to the manufacturer's instructions (Cayman, Ann Arbor, Michigan, USA) [13] [14] [15] . Briefly, 4 × 10 5 cells were lysed on ice with 2 ml of iced-cold Glutathione Assay Buffer and a rubber policeman. Thereafter, cells were collected by centrifugation (2000 g for 10 min at 4°C), the cell pellet was homogenized in 2 ml cold Glutathione Assay Buffer and vortexed for several seconds. After samples were centrifuged at 10,000 g for 15 min at 4°C, the supernatant was removed and stored on ice. The supernatant was deproteinized before assaying and then 50 μL of the samples was transferred to a 96-well plate where GSH was detected following the manufacturer's instructions through a spectrometer (BS1000 Spectra Count) at excitation/emission wavelengths of 340 and 420 nM. GSH content was expressed as nmol/10 5 cells.
ROS quantification
The oxidation of 2,7-dichlorodihydrofluorescein diacetate into 2,7-dichlorodihydrofluorescein was used to assess ROS generation, following the manufacturer's instructions (Abcam, Cambridge, United Kindom), and as previously performed [14, 15] . Briefly, cells in 96-well plates were stimulated with genistein (10 pM;1 μM) and 17 β estradiol (10 pM; 100 nM), as described for GSH measurement. After treatments, the reactions were stopped by removing medium and washing with phosphate buffer saline followed by staining with 10 µM 2,7-dichlorodihydrofluorescein diacetate for 20 min at 37°C. The fluorescence intensity of 2,7-dichlorodihydrofluorescein diacetate was measured at excitation/emission wavelengths of 485 nm and 530 nm by using a spectrometer (BS1000 Spectra Count).
Cell co-culture model
To investigate whether Huh7.5 stimulated with genistein and 17 β estradiol can exert protective effects against oxidative stress in LX-2, we co-cultured LX-2 with Huh7.5 supernatants for 24 h in 96-well plates. For co-culture, 1x10 4 Huh7.5 have been seeded and stimulated with genistein (10 pM; 100 nM; 1 μM for 30 min) and 17 β estradiol (10 pM; 10 nM; 100 nM for 30 min), alone and after 60 min pretreatment with menadione (25 µM). In some samples menadione was given together with fulvestrant (1 μM) or G15 (1 μM). After stimulation, cells were washed with phosphate buffer saline 1X and after adding new DMEM 0% FBS, without phenol red for 24 h. Then, Huh7.5 supernatants were transferred on LX-2 (1x10 4 cells seeded in 96-well plates) which have been pretreated for 60 min with menadione (Flowchart 1). At the end of stimulation, MTT and 5,51,6,61-tetrachloro-1,11,3,31 tetraethylbenzimidazolyl carbocyanine iodide assays were performed on LX-2 supernatants, whereas ROS was quantified in both Huh7.5 and LX-2 supernatants, as previously described. 
Cell lysates
The LX-2 and Huh7.5 at confluence were plated in starvation medium overnight at 37°C with 5% CO2. Western Blot analysis was performed on Huh7.5 and LX-2 treated with genistein (1 μM for 30 min) and 17 β estradiol (100 nM for 30 min) before menadione (25 µM) administrated for 60 min. In addition, Western Blot was performed on LX-2 co-cultured with Huh7.5, as previously described. At the end of stimulations, Huh7.5 and LX-2 were lysed in iced-Ripa-buffer supplemented with 1:200 sodium orthovanadate and 1:100 protease inhibitors cocktail and phenylmethanesulfonyl fluoride (1:100; Sigma). The extract proteins were quantified through bicinchoninic acid protein (Pierce, Rockford, IL, USA) and used for electrophoresis and immunoblotting studies [13] [14] [15] .
Western blotting
Cell lysates (30 μg protein each sample) dissolved in Laemmli buffer 5x, boiled for 5 min were resolved in 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis gels (Bio-Rad Laboratories, Hercules, CA, USA); after electrophoresis they were transferred to polyvinylidene fluoride membranes (Bio-Rad Laboratories), which were incubated overnight at 4°C with specific primary antibodies: anti phospho-Akt (p-Akt, 1:1000; Ser473, Santa Cruz Biotechnology, Inc., CA, USA), anti phospho-p38 MAPK (p-p38MAPK, 1:1000; Thr180/Thr182, Cell Signalling Technologies, Danvers, MA, USA), α-SMA (1:1000; Cell Signalling Technologies). The membranes were washed and then incubated with horseradish peroxidase-coupled goat anti-rabbit IgG (Sigma), peroxidase-coupled rabbit anti-goat IgG and horseradish peroxidase-coupled goat anti-mouse IgG (Sigma) for 45 min and were developed through a nonradioactive method using Western Lightning Chemiluminescence (PerkinElmer Life and Analytical Sciences, Waltham, MA, USA). Phosphorylated protein expression was calculated as a ratio towards β-actin (1:5000; Sigma).
Statistical analysis
All data were recorded using the Institution's database. Statistical analysis was performed by using STATVIEW version 5.0.1 for Microsoft Windows (SAS Institute Inc., Cary NC, USA). Data were checked for normality before statistical analysis. All the results obtained were examined through one-way ANOVA followed by Bonferroni post hoc tests. The non-parametric Mann Whitney U test for unpaired data was used to compare percentage responses. All data are presented as means ± standard deviation (SD) of five independent experiments for each experimental protocol. A value of P <0.05 was considered statistically significant.
Results
Effects of 17 β estradiol and genistein on Huh7.5
In Huh7.5 cultured in physiological conditions, 17 β estradiol and genistein improved cell viability in a dose-dependent way. As shown in Fig. 1A , both agents exerted the highest Fig. 1 . Effects of genistein (G) and 17 βestradiol (E) on Huh7.5 cell survival in physiologic/oxidative stress conditions and on mitochondrial membrane potential in oxidative stress conditions. In A, physiological conditions; in B and C, oxidative stress conditions. C = control; F: fulvestrant (1 μM); G15: G15 (1 μM). Reported data are means ± SD of five independent experiments. Short square brackets indicate significance between groups (P < 0.05). effect at 100 nM. In addition, changes in cell viability and the loss of mitochondrial membrane potential in Huh7.5 were counteracted by 17 β estradiol and genistein. In this case, the highest effect was elicited by 1 μM genistein and 100 nM 17 β estradiol (Fig. 1B and 1C) . Finally, both agents reduced ROS release in a dose-related way, while increasing GSH content ( Fig. 2A and 2B ). Also in this case, the highest effect was exerted by 1 μM genistein and 100 nM 17 β estradiol.
As shown in Fig. 1A and 1B, fulvestrant and G15 were able to counteract the effects of the estrogen and the phytoestrogens on cell viability. In addition, in presence of the blockers, Huh7.5 were less protected against the reduction of mitochondrial membrane potential caused by menadione (Fig. 1C) .
As described in Fig. 2C and 2D, the protective effects elicited by genistein and 17 β estradiol against peroxidation in Huh7.5 were accompanied by the keeping of Akt activation and the inhibition of p38MAPK phosphorylation.
Effects of direct treatment of LX-2 with 17 β estradiol and genistein
As shown in Fig. 3A , 17 β estradiol and genistein caused a slight increase of cell viability in LX-2 cultured in physiological conditions only at the highest doses. Moreover, in cells subjected to peroxidation, neither 17 β estradiol nor genistein were able to counteract the reduction of cell viability and of mitochondrial membrane potential caused by menadione ( Fig. 3B and 3C ). Those findings were accompanied by the absence of any protective effects on ROS release or GSH content and on the activation into myofibroblastic-like cells (Fig. 4A-C) . The blocking of ERs and GPER was able to reduce the effects of 17 β estradiol only on cell viability in physiological conditions (Fig. 3A) . Moreover, in LX-2 treated with the estrogens in peroxidative conditions, fulvestrant and G15 worsened cell viability and mitochondrial membrane potential. Regarding genistein, the same finding was observed in LX-2 treated with G15 only (Fig. 3B and 3C) .
Effects of co-culture of Huh7.5 and LX-2 on cell viability, mitochondrial membrane potential, and ROS release As shown in Fig. 5A , the treatment of LX-2 with the supernatants taken from Huh7.5 treated with genistein and 17 β estradiol in absence of menadione improved LX-2 viability to a greater extent in comparison with what was observed when those agents were directly Fig. 3 . Effects of genistein (G) and 17 βestradiol (E) on LX-2 cell survival in physiologic/oxidative stress conditions and on mitochondrial membrane potential in oxidative stress conditions. In A, physiological conditions; in B and C, oxidative stress conditions. Abbreviations are as in Fig. 1, 2 . Reported data are means ± SD of five independent experiments. Short square brackets indicate significance between groups (P < 0.05). 
administrated to LX-2. In addition, the effects on LX-2 were dose-related. Moreover, in peroxidative conditions, the supernatants of Huh7.5 treated with 17 β estradiol and genistein were able to counteract the reduction of mitochondrial membrane potential and the increase of ROS release by LX-2 ( Fig. 5C and 6A) . It is to note that, as previously observed, also ROS release by Huh7.5 was dose-dependently reduced by both genistein and 17 β estradiol (Fig.  6B) . Regarding cell viability, protective effects were obtained with genistein, 100 nM and 1 μM, and 17 β estradiol, 10 nM and 100 nM (Fig. 5B) . Hence, at those doses, genistein and 17 β estradiol were able to reduce the effects of menadione on cell viability of about 34% and 50%, and 50% and 60 %, respectively. As shown in Fig. 5A , the treatment of Huh7.5 with both fulvestrant and G15 was able to reduce the response of LX-2 to genistein and 17 β estradiol on cell viability in physiological conditions. Moreover, ERs and GPER blockers prevented the protection exerted by the estrogens and the phytoestrogens against the loss of mitochondrial membrane potential in LX-2 (Fig. 5C ). Regarding cell viability, only G15 could worsen the response of LX-2 to genistein and 17 β estradiol (Fig. 5B) . Western Blot analysis showed that in LX-2 co-cultured with Huh7.5, both genistein and 17 β estradiol reduced α-SMA expression, p-Akt and p 38 MAPK activation (Fig. 7) . 
Discussion
This study has shown for the first time that 17 β estradiol and genistein can differentially modulate cell viability in Huh7.5 and HSCs cultured in physiological or pathological conditions. While in absence of peroxidation both agents were able to increase cell viability, in Huh7.5 and in LX-2 co-cultured with Huh7.5 only 17 β estradiol and genistein prevented cell damage and the fall of mitochondrial membrane potential caused by menadione by modulating oxidant/antioxidant system.
In sustained inflammatory response ROS release from the lipid peroxidative processes can damage the parenchymal cell membranes and represents the starting point of liver injury [16] . In this context, the balance between oxidant/antioxidant systems can play a pivotal role [17] . Although mild liver injury usually results in an almost complete resolution, persistence of the original insult causes prolonged activation of tissue repair mechanisms, leading to hepatic fibrosis. Collagen is mainly produced by HSCs, which are regarded as the primary target for inflammatory and peroxidative stimuli and are transformed into myofibroblastic-like cells, which are able to synthesize α-SMA [18] .
In our study, 17 β estradiol, was used at a concentration range, amounting to 10 −9 -10 −7 M, which can commonly be found in menstrual/menopausal women [18, 19] . Similar doses of 17-estradiol have also been previously used in both hepatic stellate cells [18] and hepatocytes [20] in studies about protection against oxidative stress.
In Huh7.5 cultured both in physiological condition and during peroxidation, 17 β estradiol was able to improve cell viability. It is to note that oxidative stress was obtained by using the intracellular generator of hydrogen peroxide, menadione, at similar concentration as the one that was able to change GSH content in hepatocytes [21] . Furthermore, the effects of 17 β estradiol were accompanied by the prevention of ROS release and the keeping of GSH content, as previously shown about antioxidant effects of estradiol in liver [22] .
Also genistein exerted similar protective effects in Huh7.5 as those caused by the estrogens. It is to note that genistein was used at similar concentrations as the ones previously used in porcine aortic endothelial cells [12] and in hepatic stellate cells, where it was able to inhibit proliferation and counteract α-SMA expression [23] . Furthermore, the chosen doses of genistein were similar to the ones of 17 β estradiol, to enable better comparison of the effects of both agents.
In our study, genistein was more effective than the estrogens in the keeping of oxidant/ antioxidant system and cell viability. Thus, our data would support the hepatoprotective role played by soybean extracts, which could be elicited through the modulation of oxidative stress [24, 25] .
The results obtained about mitochondrial membrane potential are of particular interest. Hence maintenance of mitochondrial function is essential for the survival and normal performance of hepatocytes, which have a high energy requirement [26] . In particular, mitochondrial depolarization can result in energy crisis and in the release of apoptotic signaling molecules, which could finally encounter cell death [27] . In Huh7.5 only, both genistein and 17 β estradiol were able to counteract the fall of mitochondrial membrane potential caused by peroxidation and to keep cell survival. Although accumulating evidence indicates that 17 β estradiol can modulate the mitochondrial function in different cell lines [28] , the direct evaluation of changes of membrane potential in Huh7. 5 has not yet been fully examined. Furthermore, in vivo studies have shown negative effects of exogenous 17 β estradiol on mitochondria of ovariectomized rats [29] . Also the results obtained with genistein are quite new and in disagreement with previous ones. Hence, in isolated rat liver mitochondria genistein caused swelling, loss of membrane potential and the opening of transition pore [30] . Similar findings were obtained in human hepatocarcinoma cell lines [31] .
Phosphatidylinositol-4,5-bisphosphate 3-kinase/Akt is known to be responsible for regulation of hepatocytes cell size via its downstream molecules such as mTOR in addition to being known for its survival, anti-apoptotic and anti-oxidative properties [32, 33] . Moreover, in the liver the imbalance of oxidant/antioxidant system can also lead to the activation of stress-sensitive signaling pathways called MAPK [34, 35] . It is also worth of note that in human hepatocarcinoma cell lines cells multiple membrane-starting pathways have been reported to be rapidly activated by the ER-estradiol complex and the blockade of phospholipase C/ protein kinase C, ERK, and AKT pathways completely prevented the estradiol-induced DNA synthesis.
Those intracellular signalling downstream ERs have also been proven to have a critical role in estradiol action as a survival agent [36] In our study both 17 β estradiol and genistein were able to inhibit p38MAPK and to increase Akt phosphorylation in Huh7.5 undergone peroxidation. Those results are similar to previous findings obtained in different experimental settings [37, 38] The findings we obtained in LX-2 were quite different from those observed in Huh7.5. Thus, it is notable that any bias related to gender differences have been avoided since both cell lines were of male human origin. In the absence of peroxidation, 17 β estradiol and genistein were able to improve cell viability only at the highest doses. Moreover, 17 β estradiol was more effective than genistein. Furthermore, in LX-2 treated with menadione at similar doses as the ones previously used in HSCs [39] , either genistein or 17 β estradiol failed to protect them against the loss of cell viability and mitochondrial membrane potential and from the increased expression of α-SMA. Those results were accompanied by the absence of any effect on oxidant/antioxidant system. Interesting data were obtained by experiments of co-culture. In contrast to what was observed in LX-2 directly treated with 17 β estradiol and genistein, the treatment of LX-2 with the supernatants of Huh7.5 stimulated with all doses 17 β estradiol and genistein, was able to increase cell viability in physiologic conditions. Furthermore, in peroxidative conditions, mitochondrial membrane potential of LX-2 was prevented from collapse and the effects of menadione on cell viability and ROS release were reduced. Also those results were different from the ones obtained in LX-2 directly treated with estrogens and phytoestrogens under peroxidation. Moreover, those findings were accompanied by the inhibition of α-SMA expression and of the activation of Akt and p38MAPK, which have been reported to be involved in LX-2 myofibroblastic transformation. Thus, our findings would suggest that both Akt and p38MAPK could play a role in the intracellular pathway leading to α-SMA inhibition in LX-2 treated with supernatants of Huh7.5 [40, 41] . The co-culture experiments would confirm the importance of the cross talk between Huh7.5 and LX-2 in mediating liver progression towards fibrosis and in eliciting the protective effects of 17 β estradiol and genistein. Hence, differences obtained with treatment of LX-2 alone or in co-culture with Huh7.5 could be related to the role of paracrine stimuli derived from hepatocytes undergoing oxidative stress that could modulate HSCs cell viability/mitochondrial membrane potential whilst preventing HSCs activation and collagen synthesis. In particular, and as previously reported, HSCs activation could be inhibited by Huh7.5 through the reduction of peroxidative stimuli. Thus, the finding of our study showing a low tendency of LX-2 to mutate into myofibroblastic-like cells could be related to the reduction of ROS release by Huh7.5 treated with 17 β estradiol and genistein. Furthermore, the comparison of the results obtained in various experimental protocols involving LX-2 would highlight the importance of the keeping of mitochondrial membrane potential for preventing their activation. Hence, while in LX-2 undergone direct administration of genistein or 17 β estradiol the collapse of mitochondrial membrane potential was not counteracted and α-SMA was not inhibited, the opposite was observed in co-culture experiments.
The effects of estrogens on the liver have been reported to be related to the ER subtypes, ERα and ERβ [16] . Furthermore, one non-classical mechanism of 17 β estradiol action is through the involvement of GPER [9] , which can be predominantly found in the membrane of the endoplasmic reticulum.
Although not fully examined, our findings would suggest that both receptors could be involved in the modulation of the response to the estrogens and the phytoestrogen in both Huh7.5 and LX-2. Hence, although in the liver ERα has been reported to be the more expressed form, hepatocytes and HSCs were proven to possess more functional ERβ than ERα [2, 42, 43] . In our study, the blocking of ERs and GPER in Huh7.5 and LX-2 was able to reduce or abolish the effects of both 17 β estradiol and genistein. Those findings are in line with previous observations showing the abolishment of protective effects elicited by either 17 β estradiol or genistein in the liver [22] .
Although not clearly examined, our findings would also highlight the involvement of both MAPK and Akt in the intracellular mechanisms downstream ERs activation by either 17 β estradiol or genistein in Huh7.5 and LX-2. Those data would be in agreement with previous reports about the mechanisms of action of those agents [2, [9] [10] [11] [12] 43] .
However, further experiments will be needed to address the rate ERβ/ERα expression/ activation in Huh7.5 and LX-2 and the related intracellular signalling and to examine their crosstalk with GPER signaling [44] .
In conclusion, this study has shown that 17 β estradiol and genistein can differently exert protection against oxidative injuries in Huh7.5 and LX-2 by either direct actions or through the modulation of a cross talk between those cell lines. Those effects would be related to both ERs and GPER. Finally, our findings would support clinical observations about the different evolution of hepatic fibrosis in postmenopausal women or men versus premenopausal women and about the delay that hormone replacement therapy with estrogen would cause cirrhosis evolution in postmenopausal women [2, 5, 45] .
